Johnson & Johnson said it has settled most of the lawsuits it faced by thousands of men who claimed its anti-psychotic drug Risperdal caused them to develop excessive breast tissue and disclosed that it recorded $800 million in expenses in connection with the agreement. J&J said in a filing with the U.S. Securities and Exchange…
J&J Says COVID-19 Booster Dose Increases Antibody Levels ‘Nine-Fold’
Johnson & Johnson’s COVID-19 booster shots are able to generate high levels of antibodies and increase people’s immunity against the CCP virus, the company reported on Wednesday. The drugmaker’s latest findings are based on two Phase 2 studies conducted on people previously inoculated with its single-shot vaccine. Participants in the studies got a booster dose six…
J&J CEO Gorsky to Step Down, Company Veteran to Lead in 2022
August 20, 2021
admin
Business & EconomyCompaniescompanyEconomieseconomyhealth carehospitalsJ&JJohnson and JohnsonUSUS News
0 Comment
Johnson & Johnson will replace Chairman and CEO Alex Gorsky with another veteran company executive starting next year. The world’s biggest maker of health care products said late Thursday that Joaquin Duato will become CEO and a member of the company’s board of directors on January 3. Duato currently serves as vice chairman of Johnson…
J&J Recalls Sunscreens After Carcinogen Found in Some Sprays
Johnson & Johnson is voluntarily recalling five Neutrogena and Aveeno brand aerosol sunscreen products after detecting a cancer-causing chemical in some samples. The New Jersey-based company said on Wednesday that consumers should stop using the products and discard them, after internal testing identified low levels of benzene in some samples. J&J is also notifying distributors…
Germany Demands J&J Make up Likely Millions of Lost COVID-19 Vaccine Shots for July
Germany’s health ministry has demanded that pharmaceutical giant Johnson & Johnson provide more doses of its single-shot COVID-19 vaccine for the month of July following a shortfall of doses expected in June after millions of vaccine shots were discarded due to possible contamination concerns. Last week, the U.S. Food and Drug Administration told J&J to…
Johnson & Johnson COVID-19 Vaccine Use Should Resume: CDC Advisers
Advisers to the Centers for Disease Control and Prevention (CDC) on Friday said the Johnson & Johnson (J&J) CCP (Chinese Communist Party) virus vaccine can now be distributed with a warning. The vaccine would carry a warning about the rare risk of blood clots in those who received it, officials with the Advisory Committee on Immunization…
J&J to Cooperate in Study of Rare Blood Clots Linked to CCP Virus Vaccine
Johnson & Johnson has agreed to work with a German scientist studying rare blood clots linked to its vaccine for the CCP virus, which causes the disease COVID-19. Andreas Greinacher, a transfusion medicine expert at Greifswald University, was already studying blood clots in patients who received the AstraZeneca CCP (Chinese Communist Party) virus vaccine. Johnson & Johnson…
Seventh Case of Rare, Severe Blood Clot Linked to Paused J&J Vaccine Revealed
The Centers for Disease Control and Prevention (CDC) said Wednesday that it learned of a seventh woman who developed a rare and severe type of blood clot after receiving the Johnson & Johnson COVID-19 vaccine. The seventh possible patient was identified as a 28-year-old woman as the Advisory Committee on Immunization Practices debates whether the J&J…
7th Case of Rare, Severe Blood Clot Linked to J&J Vaccine
The Centers for Disease Control and Prevention (CDC) said on April 14 that it learned of a seventh woman who developed a rare and severe type of blood clot after receiving the Johnson & Johnson (J&J) COVID-19 vaccine. The seventh possible patient was identified as a 28-year-old woman, as the Advisory Committee on Immunization Practices…
CDC Vaccine Advisory Committee Says J&J COVID-19 Vaccine to Remain on Pause
April 15, 2021
admin
AMERICACCP VirusCDCCOVID-19Health EducationJ&JPUBLIC HEALTH INFORMATIONUSUS NewsVaccineVaccines & Safety
0 Comment
The Johnson & Johnson (J&J) COVID-19 vaccine will remain on pause after an advisory committee to the Centers for Disease Control and Prevention (CDC) said it needed more data to be able to vote on a recommendation, which may come in a week to 10 days. Federal health officials halted the use of the J&J…
US News
RSS Error: A feed could not be found at `https://www.theepochtimes.com/c-us/feed`; the status code is `200` and content-type is `text/html; charset=utf-8`